Clinical Research Directory

"Inclusion Criteria": * Adults aged 18 years or older. * Confirmed diagnosis of stroke (ischemic or hemorrhagic) at least 6 months prior to enrollment. * Clinically diagnosed muscle spasticity, measured by the Modified Ashworth Scale (MAS), with a score of 0 to 3. * Stable medical condition that permits participation in the intervention. * No significant changes in spasticity-related treatment for at least 3 months prior to the study. * Ability to provide written informed consent to participate in the study. * Ability to attend weekly sessions and follow-up visits as required. "Exclusion Criteria": * Severe spasticity or contractures unresponsive to prior treatments. * Contraindications to Shock Wave Therapy, including: * Local infections in the treatment area. * Known or suspected malignancy near the treatment site. * Severe bleeding disorders or anticoagulation therapy. * Pregnancy. * Neurological conditions other than stroke that could interfere with study outcomes (e.g., Parkinson's disease, multiple sclerosis). * Recent treatments that might interfere with spasticity assessment, including: * Injections of botulinum toxin within the past 6 months. * Recent surgery or other interventions targeting spasticity. * Cognitive impairment or other conditions preventing the participant from following instructions or completing study tasks. * Severe cardiovascular, renal, or hepatic disease that might complicate therapy or participation. * Inability to commit to follow-up visits or complete the intervention protocol due to logistical, mobility, or health-related issues.